companydata.dkReshape ApS: Financial statements 2025
CVR: 40056173
Reshape ApS (CVR 40056173) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 6,603,206 and a net result of DKK -35,557,856 compared with DKK -12,222,020 the year before. That is an increase of 281.9% compared with the year before. Equity amounted to DKK 36,562,988. The solvency ratio was 83.6%. The company had 51 employees in the financial year.
- Gross Profit
- 6,603,206 kr.
- Profit/Loss
- -35,557,856 kr.
- Equity
- 36,562,988 kr.
- Total Assets
- 43,713,434 kr.
- Employees
- 51
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 6.6 mio. | -35.6 mio. | 36.6 mio. | 51 |
| 2024 | - | 1.7 mio. | -12.2 mio. | 25.1 mio. | 18 |
| 2023 | - | 2 mio. | -4.6 mio. | 26.9 mio. | 10 |
| 2022 | - | -118 t. | -1.6 mio. | 5.5 mio. | 16 |
| 2021 | - | 593 t. | 52 t. | 1.3 mio. | 7 |
Find more companies like Reshape ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout Reshape ApS
Reshape ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Magnus Nyborg Madsen, Daniel Storgaard and Carl-Emil Grøn Fuglesang. The company is owned by Reshape Biotech Inc.. In 2026, the company reported a gross profit of DKK 5,310,622 and a net result of DKK -42,643,506 compared with DKK -35,557,856 the year before. Equity amounted to DKK 75,515,117.